|
This letter from DuPont provides a supplement to a previous submission regarding a longitudinal study on perfluorooctanoate (PFOA), indicating that increased serum PFOA levels are associated with higher total cholesterol and changes in liver function indicators among employees at the DuPont Washington Works plant, although DuPont does not consider this information to constitute substantial risk under TSCA 8(e).
|
2007 |
AR226-3768
|
mq9x01doDon6DaLkRqo7vZO6B |
2 |